EUVIMEDEUVIMED entdecken
Crossref

Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation

Cunrui Li, Mingchao Zhu, Songqi Liu, Jiaming Zhang, Hui Ye iD, Chen Zhang, Duorui Ji, Haoyang Tang, Yihua Zhang iD, Jianbing Wu iD, Zhangjian Huang iD

Journal of Medicinal Chemistry · 26.09.2024 · 67 (18) · 16311-16327

DOI: 10.1021/acs.jmedchem.4c01199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.08.2024. Verfasst von Cunrui Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Glaucoma, rho-Associated Kinases, Nitric Oxide, Nitric Oxide Donors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region, China Pharmaceutical University, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the synergistic therapeutic effect of nitric oxide (NO) and Rho-associated protein kinase (ROCK) inhibitors on glaucoma, a series of NO-donating Netarsudil derivatives were designed, synthesized, and their activities in vitro and in vivo were evaluated. Among them, (S)-10e released an appropriate amount of NO in aqueous humor in vitro and displayed potent ROCK inhibition. Topical administration of (S)-10e significantly lowered intraocular pressure in an acute ocular hypertension rabbit model and protected retinal ganglion cells in a magnetic microbead occlusion mouse model. A metabolism investigation revealed that (S)-10e released 7a, a metabolite after NO releasing, and 13, an active metabolite of (S)-Netarsudil, in rabbit eyes. Notably, introducing an NO donor moiety attenuated ROCK inhibition-induced ocular irritation in an sGC-independent manner, suggesting that the attenuated conjunctival hyperemia effect of (S)-10e is related to the NO-induced protein S-nitrosation of phosphodiesterase 3A (PDE3A). Overall, (S)-10e is a promising candidate for glaucoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucomarho-Associated KinasesNitric OxideNitric Oxide DonorsIntraocular PressureAnimalsRabbitsBenzoatesMiceMaleDrug Synergismbeta-AlanineProtein Kinase InhibitorsStructure-Activity RelationshipHumans

Substanzen

netarsudilrho-Associated KinasesNitric OxideNitric Oxide DonorsBenzoatesbeta-AlanineProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
  • School of Pharmacy, Key Laboratory of Active Components of Xinjiang Natural Medicine and Drug Release Technology, Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Xinjiang Medical University…

ORCID-Profile: Hui Ye, Yihua Zhang, Jianbing Wu, Zhangjian Huang

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region
  • China Pharmaceutical University
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia

Zitieren

APA

Li, C., Zhu, M., Liu, S., Zhang, J., Ye, H., Zhang, C., Ji, D., Tang, H., Zhang, Y., Wu, J., & Huang, Z. (2024). Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation. Journal of Medicinal Chemistry, 67(18), 16311-16327. https://doi.org/10.1021/acs.jmedchem.4c01199

Vancouver

Li C, Zhu M, Liu S, Zhang J, Ye H, Zhang C, et al. Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation. Journal of Medicinal Chemistry. 2024;67(18):16311-16327. doi:10.1021/acs.jmedchem.4c01199

BibTeX
@article{Li2024,
  author = {Li, Cunrui and Zhu, Mingchao and Liu, Songqi and Zhang, Jiaming and Ye, Hui and Zhang, Chen and Ji, Duorui and Tang, Haoyang and Zhang, Yihua and Wu, Jianbing and Huang, Zhangjian},
  title = {Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {18},
  pages = {16311--16327},
  doi = {10.1021/acs.jmedchem.4c01199}
}
Kostenlos starten →